We are live on ! Find out more
Arrowstreet Capital

Arrowstreet Capital Portfolio holdings

AUM $185B
1-Year Est. Return 39.58%
This Fund
S&P 500
This Quarter Est. Return
+10.23%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43B
AUM Growth
+$121M
Cap. Flow
-$3.21B
Cap. Flow %
-7.47%
Top 10 Hldgs %
18.86%
Holding
2,029
New
505
Increased
717
Reduced
446
Closed
331

Top Buys

Rank Stock Value
1
INTC icon
Intel
INTC
+$285M
2
AMAT icon
Applied Materials
AMAT
+$234M
3
MU icon
Micron Technology
MU
+$185M
4
MRK icon
Merck
MRK
+$161M
5
NXPI icon
NXP Semiconductors
NXPI
+$152M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$505M
2
BAC icon
Bank of America
BAC
+$339M
3
NKE icon
Nike
NKE
+$335M
4
UNP icon
Union Pacific
UNP
+$329M
5
C icon
Citigroup
C
+$277M

Sector Composition

Rank Sector Weight
1 Technology 23.49%
2 Financials 16.82%
3 Consumer Discretionary 16.55%
4 Healthcare 14.39%
5 Industrials 8.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRTO icon
776
Criteo S.A. Ordinary Shares
CRTO
$908M
$6.47M 0.02%
373,086
+158,585
+74% +$2.82M
WSBF icon
777
Waterstone Financial
WSBF
$374M
$6.46M 0.02%
339,505
+148,373
+78% +$2.73M
RS icon
778
Reliance Steel & Aluminium
RS
$21.8B
$6.45M 0.02%
+53,877
New +$6.1M
EXPR
779
DELISTED
Express, Inc.
EXPR
$6.42M 0.01%
65,887
+29,940
+83% +$2.35M
SCHL icon
780
Scholastic
SCHL
$800M
$6.41M 0.01%
166,772
+78,339
+89% +$2.95M
IRWD icon
781
Ironwood Pharmaceuticals
IRWD
$679M
$6.41M 0.01%
+481,624
New +$5.31M
CIVI
782
DELISTED
Civitas Resources
CIVI
$6.41M 0.01%
+274,582
New +$5.43M
EXPE icon
783
Expedia Group
EXPE
$37.2B
$6.4M 0.01%
59,222
+14,676
+33% +$1.72M
IVV icon
784
iShares Core S&P 500 ETF
IVV
$905B
$6.4M 0.01%
19,800
-7,172
-27% -$2.22M
PFLT icon
785
PennantPark Floating Rate Capital
PFLT
$730M
$6.37M 0.01%
523,221
+323,442
+162% +$3.84M
WLH
786
DELISTED
WILLIAM LYON HOMES
WLH
$6.34M 0.01%
+317,387
New +$6.48M
CE icon
787
Celanese
CE
$4.81B
$6.32M 0.01%
51,367
+47,867
+1,368% +$5.89M
CRSP icon
788
CRISPR Therapeutics
CRSP
$5.23B
$6.32M 0.01%
+103,800
New +$5.67M
B
789
Barrick Mining
B
$68B
$6.31M 0.01%
339,717
+77,105
+29% +$1.32M
HI
790
DELISTED
Hillenbrand
HI
$6.28M 0.01%
188,483
+56,189
+42% +$1.77M
CPF icon
791
Central Pacific Financial
CPF
$992M
$6.27M 0.01%
211,835
+26,316
+14% +$768K
NPTN
792
DELISTED
NEOPHOTONICS CORP
NPTN
$6.23M 0.01%
706,832
+625,052
+764% +$4.68M
GFF icon
793
Griffon
GFF
$4.74B
$6.21M 0.01%
305,563
+291,663
+2,098% +$6.13M
CTT
794
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
$6.21M 0.01%
541,506
+327,383
+153% +$3.73M
KNL
795
DELISTED
Knoll, Inc.
KNL
$6.21M 0.01%
245,643
+161,374
+191% +$4.26M
LCI
796
DELISTED
Lannett Company, Inc.
LCI
$6.19M 0.01%
175,496
+73,345
+72% +$2.98M
NCMI icon
797
National CineMedia
NCMI
$373M
$6.17M 0.01%
84,610
-1,097
-1% -$82.6K
WOW
798
DELISTED
WideOpenWest
WOW
$6.15M 0.01%
828,302
+167,816
+25% +$1.06M
FLO icon
799
Flowers Foods
FLO
$1.52B
$6.13M 0.01%
282,178
+255,378
+953% +$5.55M
ALV icon
800
Autoliv
ALV
$8.92B
$6.12M 0.01%
72,540
+58,640
+422% +$4.8M

Similar funds

Arrowstreet Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Arrowstreet Capital held 2,029 positions worth $43B, up 0.28% from $42.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Arrowstreet Capital withdrew a net $3.21B in Q4 2019, closing 331 positions and reducing 446 holdings. Its most notable exit was Celgene Corp, an estimated $505M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Arrowstreet Capital opened a new position in Edwards Lifesciences worth $127M.

  • Arrowstreet Capital's largest Q4 2019 buy was Edwards Lifesciences: 1,637,208 shares worth $127M.
  • Arrowstreet Capital added most to Intel in Q4 2019, an estimated $285M increase.
  • Arrowstreet Capital's biggest Q4 2019 reduction was Union Pacific, cutting an estimated $329M.
  • Arrowstreet Capital fully exited Celgene Corp in Q4 2019, selling an estimated $505M.
  • Arrowstreet Capital's ten largest holdings make up 19% of its $43B portfolio in Q4 2019.
  • Arrowstreet Capital opened 505 new positions and closed 331 in Q4 2019.
  • Arrowstreet Capital's portfolio value rose 0.28% quarter-over-quarter to $43B.

Based on Arrowstreet Capital's 13F filing for Q4 2019, filed 13 Feb 2020.